Pielech Melissa, Kruger Eric, Rivers William Evan, Snow Harry E, Vowles Kevin E
Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, United States.
Department of Psychology, University of New Mexico, Albuquerque, NM, United States.
Pain. 2020 Jun;161(6):1297-1310. doi: 10.1097/j.pain.0000000000001812.
Data on all outpatient opioid prescriptions (N = 71,647) to youth below age 21 (N = 42,020) from 2005 to 2016 were extracted from electronic medical records within a university hospital system in New Mexico (NM) as were demographic details and markers of morbidity/mortality. Relative risk was calculated for markers of morbidity/mortality based on sociodemographic characteristics. The sample was primarily male (55.0%), Hispanic/Latinx (50.1%), English-speaking (88.9%), and publicly insured (50.1%). Mean age was 13.54 (SD = 6.50). From 2005 to 2016, overall frequency of opioid prescriptions increased by 86.6% (from 2470 to 4610) with the largest increase (206.2%) observed from 2005 to 2008 (2470-7562). Patients who were older, white, and non-Hispanic were more likely to receive multiple opioid prescriptions. Large relative increases in morbidity and mortality were documented, although base rates remained low. The percentage of individuals within the sample who experienced an overdose increased steadily from 0 in 2005 to 1.09% in 2016. Incidence of mortality increased from 0.12% of the sample to 1.39% in 2016. The proportion of individuals who received a medication for the treatment of opioid dependence increased from 0.06% in 2005 to 0.44% in 2016. Significantly increased risk of adverse outcomes was observed in patients receiving multiple opioid prescriptions, and in patients who were older, of minority race, received their first prescription in an outpatient clinic, and publicly insured or uninsured. Results add to the growing literature concerning opioid prescription rates over time. They also provide important information on potential additive risks of adverse outcomes when pediatric patients receive multiple opioid prescriptions.
2005年至2016年期间,新墨西哥州(NM)一家大学医院系统的电子病历中提取了所有给21岁以下青少年(N = 42,020)的门诊阿片类药物处方数据(N = 71,647),以及人口统计学细节和发病率/死亡率指标。根据社会人口学特征计算发病率/死亡率指标的相对风险。样本主要为男性(55.0%)、西班牙裔/拉丁裔(50.1%)、说英语(88.9%)和参加公共保险(50.1%)。平均年龄为13.54岁(标准差 = 6.50)。2005年至2016年期间,阿片类药物处方的总体频率增加了86.6%(从2470增加到4610),其中2005年至2008年期间增加幅度最大(206.2%)(从2470增加到7562)。年龄较大、白人且非西班牙裔的患者更有可能接受多次阿片类药物处方。尽管基数仍然较低,但发病率和死亡率有较大的相对增加。样本中经历药物过量的个体百分比从2005年的0稳步增加到2016年的1.09%。死亡率从样本的0.12%增加到2016年的1.39%。接受阿片类药物依赖治疗药物的个体比例从2005年的0.06%增加到2016年的0.44%。在接受多次阿片类药物处方的患者中,以及年龄较大、少数族裔、在门诊诊所首次开具处方、参加公共保险或未参保的患者中,观察到不良结局风险显著增加。研究结果进一步丰富了关于阿片类药物随时间变化的处方率的文献。它们还提供了重要信息,说明儿科患者接受多次阿片类药物处方时不良结局的潜在附加风险。